Abiopharma

🔍 Foster Byron S. (Executive)

Company: DANA Inc (DAN)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 333 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,117.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.